Assessing the Minimum Number of Data Points Required for Accurate IC 50 Determination
- 1 October 2005
- journal article
- research article
- Published by SAGE Publications in ASSAY and Drug Development Technologies
- Vol. 3 (5) , 525-531
Abstract
Combinatorial chemistry technology has enabled the synthesis of large, targeted libraries consisting of a much higher ratio of pharmacologically active compounds than traditional compound archives. This has resulted in a higher number of compounds requiring follow-up characterisation in full 50% inhibitory concentration (IC50) curves after the preliminary screen. The aim of this study was to develop a new assay format and analysis protocol for IC50 determination from the minimum number of data points so that more information could be derived from a primary inhibition screen. Data points from existing 10-point IC50 curves were used retrospectively to test the accuracy of IC50 predictions derived from just one or two compound concentrations. Regression analysis showed that both methods were useful, although, as expected, two compound concentrations gave more accurate IC50 predictions. A final experimental data set comparing IC50 values derived from a two- and 10- point assay format gave highly comparable data (r 2 = 0.89). This study shows that it is possible to generate IC50 values from an appropriately designed primary inhibition screen using two compound concentrations, reducing the requirement for follow-up IC50 determinations.Keywords
This publication has 7 references indexed in Scilit:
- Optimizing Higher Throughput Methods to Assess Drug–Drug Interactions for CYP1A2, CYP2C9, CYP2C19, CYP2D6, rCYP2D6, and CYP3A4 In Vitro Using a Single Point IC50SLAS Discovery, 2002
- Life in the fast lane: high-throughput chemistry for lead generation and optimisation.Journal of Cellular Biochemistry, 2001
- Chapter 27. Application of Combinatorial and Parallel Synthesis to Medicinal Chemistry1999
- Fully automated analysis of activities catalysed by the major human liver cytochrome P450 (CYP) enzymes: assessment of human CYP inhibition potentialXenobiotica, 1999
- Molecular Cloning of Human Eotaxin, an Eosinophil-selective CC Chemokine, and Identification of a Specific Eosinophil Eotaxin Receptor, CC Chemokine Receptor 3Journal of Biological Chemistry, 1996
- Estimation of antagonist Kb from inhibition curves in functional experiments: alternatives to the Cheng-Prusoff equationTrends in Pharmacological Sciences, 1993
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973